The relationship between mean platelet volume and thrombosis recurrence in patients diagnosed with antiphospholipid syndrome

Rheumatology International

Volumn 34, Issue 11, 2014, Pages 1599-1605

  Rupa Matysek, Joanna ^a   Gil, Lidia ^a   Wojtasińska, Ewelina ^a   Ciepłuch, Katarzyna ^a   Lewandowska, Maria ^a   Komarnicki, Mieczysław ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Antiphospholipid antibody syndrome; Mean platelet volume; Thrombosis recurrence

Indexed keywords

BIOLOGICAL MARKER;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; AREA UNDER THE CURVE; BLOOD; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; COMPLICATION; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PREGNANCY; RECEIVER OPERATING CHARACTERISTIC; RECURRENT DISEASE; RISK; RISK FACTOR; STATISTICAL MODEL; THROMBOCYTE ACTIVATION; THROMBOCYTE VOLUME; THROMBOSIS; YOUNG ADULT;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; AREA UNDER CURVE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MEAN PLATELET VOLUME; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PLATELET ACTIVATION; PREDICTIVE VALUE OF TESTS; PREGNANCY; RECURRENCE; RISK FACTORS; ROC CURVE; THROMBOSIS; YOUNG ADULT;

EID: 84896555471     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-014-2996-0     Document Type: Article

References (29)

1. Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA et al (2012) Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e195S–e226S
2. Biggioggero M, Meroni PL (2010) The geoepidemiology of the antiphospholipid antibody syndrome. Autoimmun Rev 9:A299–A304
3. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306
4. Adams M (2008) Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation. Semin Thromb Hemost 34:251–255
5. Pierangeli SS, Chen PP, Raschi E, Scurati S, Grossi C, Borghi MO et al (2008) Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms. Semin Thromb Hemost 34:236–250
6. Urbanus RTDR, de Groot PG (2008) Platelets and the antiphospholipid syndrome. Lupus 17:888–894
7. Braekkan SK, Mathiesen EB, Njolstad I, Wilsgaard T, Stormer J, Hansen JB (2010) Mean platelet volume is a risk factor for venous thromboembolism: the Tromso study, Tromso, Norway. J Thromb Haemost 8:157–162
8. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B et al (2010) Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 8:148–156
9. Kruse L, Mitchell AM, Camargo CA Jr, Hernandez J, Kline JA (2006) Frequency of thrombophilia-related genetic variations in patients with idiopathic pulmonary embolism in an urban emergency department. Clin Chem 52:1026–1032
10. Biswas A, Ranjan R, Meena A, Akhter S, Sharma V, Yadav BK et al (2009) Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians. Thromb Res 124:397–402
11. Vizioli L, Muscari S, Muscari A (2009) The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract 63:1509–1515
12. Mehdi AA, Uthman I, Khamashta M (2010) Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future. Eur J Clin Invest 40:451–464
13. Kamath S, Blann AD, Lip GY (2001) Platelet activation: assessment and quantification. Eur Heart J 22:1561–1571
14. Bath PM, Butterworth RJ (1996) Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 7:157–161
15. Kaplan ZS, Jackson SP (2011) The Role of Platelets in Atherothrombosis. Hematology Am Soc Hematol Educ Program 51-61
16. Kandis H, Ozhan H, Ordu S, Erden I, Caglar O, Basar C et al (2011) The prognostic value of mean platelet volume in decompensated heart failure. Emerg Med J 28:575–578
17. Kostrubiec M, Labyk A, Pedowska-Wloszek J, Hrynkiewicz-Szymanska A, Pacho S, Jankowski K et al (2010) Mean platelet volume predicts early death in acute pulmonary embolism. Heart 96:460–465
18. Ha SI, Choi DH, Ki YJ, Yang JS, Park G, Chung JW et al (2011) Stroke prediction using mean platelet volume in patients with atrial fibrillation. Platelets 22:408–414
19. Bath P, Algert C, Chapman N, Neal B (2004) Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 35:622–626
20. Turner-Stokes L, Jones D, Patterson KG, Todd-Pokropek A, Isenberg DA, Goldstone AH (1991) Measurement of haematological indices of chronic rheumatic disease with two newer generation automated systems, the H1 and H6000 (Technicon). Ann Rheum Dis 50:583–587
21. Dasanu CA, Codreanu I (2011) Isolated thrombocytopenia: should we routinely screen for antiphospholipid antibodies? Conn Med 75:281–284
22. Pengo V, Ruffatti A, Legnani C, Gresele P, Barcellona D, Erba N et al (2010) Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost 8:237–242
23. Ruffatti A, Tonello M, Del Ross T, Cavazzana A, Grava C, Noventa F et al (2006) Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost 96:337–341
24. Tangelder MJ, van Hattum ES (2010) Antithrombotic therapy in peripheral artery disease-antiplatelet therapy, anticoagulants, both or none. Thromb Haemost 104:196–199
25. Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837–1847
26. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD (2011) Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 17:47–58
27. Korkmaz S, Uslu AU, Sahin S, Senel S, Sencan M (2013) Is there a link between mean platelet volume and thrombotic events in antiphospholipid syndrome? Platelets. doi:10.3109/09537104.2013.824563
28. Chamley LW, McKay EJ, Pattison NS (1993) Inhibition of heparin/antithrombin III cofactor activity by anticardiolipin antibodies: a mechanism for thrombosis. Thromb Res 71:103–111
29. Hoffmann JJ (2012) Reference range of mean platelet volume. Thromb Res 129:534–535